Updates on targeted therapies for acute myeloid leukaemia

S Kayser, MJ Levis - British journal of haematology, 2022 - Wiley Online Library
In the past few years research in the underlying pathogenic mechanisms of acute myeloid
leukaemia (AML) has led to remarkable advances in our understanding of the disease …

Updates on targeted therapies for acute myeloid leukaemia

S Kayser, MJ Levis - British journal of haematology, 2022 - pubmed.ncbi.nlm.nih.gov
In the past few years research in the underlying pathogenic mechanisms of acute myeloid
leukaemia (AML) has led to remarkable advances in our understanding of the disease …

Updates on targeted therapies for acute myeloid leukaemia

S Kayser, MJ Levis - British Journal of Haematology, 2021 - cir.nii.ac.jp
抄録< jats: title> Summary</jats: title>< jats: p> In the past few years research in the
underlying pathogenic mechanisms of acute myeloid leukaemia (AML) has led to …

Updates on targeted therapies for acute myeloid leukaemia.

S Kayser, MJ Levis - British Journal of Haematology, 2021 - europepmc.org
In the past few years research in the underlying pathogenic mechanisms of acute myeloid
leukaemia (AML) has led to remarkable advances in our understanding of the disease …

[PDF][PDF] Updates on targeted therapies for acute myeloid leukaemia

S Kayser, MJ Levis - scholar.archive.org
In the past few years research in the underlying pathogenic mechanisms of acute myeloid
leukaemia (AML) has led to remarkable advances in our understanding of the disease …

Updates on targeted therapies for acute myeloid leukaemia.

S Kayser, MJ Levis - British Journal of Haematology, 2022 - search.ebscohost.com
In the past few years research in the underlying pathogenic mechanisms of acute myeloid
leukaemia (AML) has led to remarkable advances in our understanding of the disease …

Updates on targeted therapies for acute myeloid leukaemia

S Kayser, MJ Levis - British journal of haematology, 2022 - pure.johnshopkins.edu
In the past few years research in the underlying pathogenic mechanisms of acute myeloid
leukaemia (AML) has led to remarkable advances in our understanding of the disease …